Browsing eNauka

Browsing by Author Reck, Martin

Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)TypeМp-cat.
2024Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 TrialReck, Martin; ...; Andric, Zoran G  ; ...; (broj, koautora 18)Article
21a+M21a+
2018First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerHorn, Leora; Mansfield, Aaron S.; Szczęsna, Aleksandra; Havel, Libor; Krzakowski, Maciej; Hochmair, Maximilian J.; Huemer, Florian; Losonczy, György; Johnson, Melissa L.; Nishio, Makoto;
Reck, Martin; Mok, Tony; Lam, Sivuonthanh; Shames, David S.; Liu, Juan; Ding, Beiying; Lopez-Chavez, Ariel; Kabbinavar, Fairooz; Lin, Wei; Sandler, Alan; Liu, Stephen V.;
Article
21a+M21a+
2024Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension studyReck, Martin; ...; Andric, Zoran G  ; ...; (broj, koautora 24)Article
21M21
2015Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trialThatcher, Nick; Hirsch, Fred R; Luft, Alexander V; Szczesna, Aleksandra; Ciuleanu, Tudor E; Dediu, Mircea; Ramlau, Rodryg; Galiulin, Rinat K; Bálint, Beatrix; Losonczy, György;
Kazarnowicz, Andrzej; Park, Keunchil; Schumann, Christian; Reck, Martin; Depenbrock, Henrik; Nanda, Shivani; Kruljac-Letunic, Anamarija; Kurek, Raffael; Paz-Ares, Luis; Socinski, Mark A;
Article
21a+M21a+